Lionco Pharmaceutical Group Co.,Ltd. (SHA:603669)

SHA:603669 Revenue

Lionco Pharmaceutical Group had revenue of 86.54M CNY in the quarter ending March 31, 2026, with 72.65% growth. This brings the company's revenue in the last twelve months to 358.90M, up 1.66% year-over-year. In the year 2025, Lionco Pharmaceutical Group had annual revenue of 322.48M, down -15.09%.

• Revenue (ttm): 358.90M
• Revenue Growth: +1.66%
• P/S Ratio: 12.00
• Revenue / Employee: 1.26M
• Employees: 284
• Market Cap: 4.31B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	322.48M	-57.30M	-15.09%
Dec 31, 2024	379.78M	182.95M	92.95%
Dec 31, 2023	196.83M	-92.43M	-31.95%
Dec 31, 2022	289.26M	-451.06M	-60.93%
Dec 31, 2021	740.33M	-260.67M	-26.04%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 2, 2026

Data Sources Report a data error